These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11078981)

  • 1. Use of human GH in elderly patients with accidental hip fracture.
    Van der Lely AJ; Lamberts SW; Jauch KW; Swierstra BA; Hertlein H; Danielle De Vries D; Birkett MA; Bates PC; Blum WF; Attanasio AF
    Eur J Endocrinol; 2000 Nov; 143(5):585-92. PubMed ID: 11078981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: a double-blind placebo-controlled pilot study in 20 patients.
    Hedström M; Sääf M; Brosjö E; Hurtig C; Sjöberg K; Wesslau A; Dalén N
    Acta Orthop Scand; 2004 Aug; 75(4):394-401. PubMed ID: 15370581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
    Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture.
    Yeo AL; Levy D; Martin FC; Sönksen P; Sturgess I; Wheeler MM; Young A
    Growth Horm IGF Res; 2003 Dec; 13(6):361-70. PubMed ID: 14624771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional supplementation of elderly hip fracture patients. A randomized, double-blind, placebo-controlled trial.
    Espaulella J; Guyer H; Diaz-Escriu F; Mellado-Navas JA; Castells M; Pladevall M
    Age Ageing; 2000 Sep; 29(5):425-31. PubMed ID: 11108415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone increases breast milk volumes in mothers of preterm infants.
    Gunn AJ; Gunn TR; Rabone DL; Breier BH; Blum WF; Gluckman PD
    Pediatrics; 1996 Aug; 98(2 Pt 1):279-82. PubMed ID: 8692630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
    Bach MA; Rockwood K; Zetterberg C; Thamsborg G; Hébert R; Devogelaer JP; Christiansen JS; Rizzoli R; Ochsner JL; Beisaw N; Gluck O; Yu L; Schwab T; Farrington J; Taylor AM; Ng J; Fuh V;
    J Am Geriatr Soc; 2004 Apr; 52(4):516-23. PubMed ID: 15066065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic steroids for rehabilitation after hip fracture in older people.
    Farooqi V; Berg ME; Cameron ID; Crotty M
    Sao Paulo Med J; 2016; 134(5):467-468. PubMed ID: 27901247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations.
    Cohn L; Feller AG; Draper MW; Rudman IW; Rudman D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):417-25. PubMed ID: 8287568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients.
    Chu LW; Lam KS; Tam SC; Hu WJ; Hui SL; Chiu A; Chiu KC; Ng P
    J Clin Endocrinol Metab; 2001 May; 86(5):1913-20. PubMed ID: 11344184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial.
    Schürch MA; Rizzoli R; Slosman D; Vadas L; Vergnaud P; Bonjour JP
    Ann Intern Med; 1998 May; 128(10):801-9. PubMed ID: 9599191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An initial loading-dose vitamin D versus placebo after hip fracture surgery: randomized trial.
    Mak JC; Mason RS; Klein L; Cameron ID
    BMC Musculoskelet Disord; 2016 Aug; 17():336. PubMed ID: 27515154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis.
    Shinobe M; Sanaka T; Nihei H; Sugino N
    Nephron; 1997; 77(1):29-36. PubMed ID: 9380235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries.
    Roth E; Valentini L; Semsroth M; Hölzenbein T; Winkler S; Blum WF; Ranke MB; Schemper M; Hammerle A; Karner J
    J Trauma; 1995 Jan; 38(1):136-41. PubMed ID: 7538170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving community ambulation after hip fracture: protocol for a randomised, controlled trial.
    Orwig D; Mangione KK; Baumgarten M; Terrin M; Fortinsky R; Kenny AM; Gruber-Baldini AL; Beamer B; Tosteson A; Shardell M; Magder L; Binder E; Koval K; Resnick B; Craik RL; Magaziner J
    J Physiother; 2017 Jan; 63(1):45-46. PubMed ID: 27964962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study.
    Adunsky A; Chandler J; Heyden N; Lutkiewicz J; Scott BB; Berd Y; Liu N; Papanicolaou DA
    Arch Gerontol Geriatr; 2011; 53(2):183-9. PubMed ID: 21067829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
    Sääf M; Hilding A; Thorën M; Troell S; Hall K
    Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V; Luo M; Fernández-Estívariz C; Gu LH; Bazargan N; Klapproth JM; Sitaraman SV; Galloway JR; Leader LM; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2006; 30(6):480-6. PubMed ID: 17047171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.